M. Beaudoin

Triple VPI CGS 35601 Reduces High Blood Pressure in Low-Renin, High-Salt Dahl Salt-Sensitive Rats

P. Daull, F. Nantel, D. Arsenault, 2006, Experimental biology and medicine.

Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.

P. Daull, F. Nantel, O. Benrezzak, 2005, American journal of hypertension.

The First Preclinical Pharmacotoxicological Safety Assessment of CGS 35601, a Triple Vasopeptidase Inhibitor, in Chronically Instrumented, Conscious, and Unrestrained Spontaneously Hypertensive Rats

P. Daull, F. Nantel, O. Benrezzak, 2006, Drug and chemical toxicology.

The Hemodynamic and Metabolic Profiles of Zucker Diabetic Fatty Rats Treated with a Single Molecule Triple Vasopeptidase Inhibitor, CGS 35601

P. Daull, F. Nantel, S. Gadbois, 2006, Experimental biology and medicine.

Profiling biochemical and hemodynamic markers using chronically instrumented, conscious and unrestrained rats undergoing severe, acute controlled hemorrhagic hypovolemic shock as an integrated in-vivo model system to assess new blood substitutes.

P. Daull, F. Nantel, K. Belleville, 2005, Vascular pharmacology.

Integrated in vivo pharmacology using an instrumented, unrestrained and conscious rat platform: application to rat models of diabetes.

P. Daull, F. Nantel, O. Benrezzak, 2006, Journal of pharmacological and toxicological methods.

Deregulation of cyclooxygenase and nitric oxide synthase gene expression in the inflammatory cascade triggered by experimental group B streptococcal meningitis in the newborn brain and cerebral microvessels.

F. Noya, M. Glibetić, J. Aranda, 1999, Seminars in perinatology.